Dermatologists’ Case Files:

Use of Immune Response Modifier Therapy in Challenging Patients

A supplement to Skin & Allergy News, supported by an educational grant from 3M Pharmaceuticals and designated by the American Academy of Dermatology (AAD) for AAD continuing medical educational (CME) credit.

To View pdf of CME Post-Test, Click Here